The C677T mutation in the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients

Autor: Ede, A.E. van, Laan, R.F.J.M., Blom, H.J., Huizinga, T.W.J., Haagsma, C.J., Giesendorf, B.A.J., Boo, T.M. de, Putte, L.B.A. van de

Publikováno v: Arthritis and Rheumatism, 44, 2525-30
Arthritis and Rheumatism, 44, 11, pp. 2525-30

Item does not contain fulltext OBJECTIVE: To study the possible relationship between the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene and the toxicity and efficacy of treatment with methotrexate (MTX) in patients with rheuma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::16f9aa4b7f00f46212517d7abea023cd
https://hdl.handle.net/2066/185789

Effect of methotrexate alone or in combination with sulphasalazine on the production and circulating concentrations of cytokines and their antagonists. Longitudinal evaluations in patients with rheumatoid arthritis

Autor: Barrera Rico, P., Haagsma, C.J., Boerbooms, A.M.T., Riel, P.L.C.M. van, Borm, G.F., Putte, L.B.A. van de, Meer, J.W.M. van der

Publikováno v: British Journal of Rheumatology, 34, pp. 747-755
British Journal of Rheumatology, 34, 747-755

Item does not contain fulltext 9 p.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7fe9b03bb4d786bfd6a74c074148073f
https://hdl.handle.net/2066/21894

Implementation of a treat-to-target strategy in very early rheumatoid arthritis: results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort study

Autor: Vermeer, M., Kuper, H.H., Hoekstra, M., Haagsma, C.J., Posthumus, M.D., Brus, H.L., van Riel, P.L., Laar, M.A. van der

Publikováno v: Arthritis & rheumatism, 63(10), 2865-2872. Wiley
Arthritis and Rheumatism, 63, 2865-72
ARTHRITIS AND RHEUMATISM, 63(10), 2865-2872. John Wiley and Sons Inc.
Arthritis and Rheumatism, 63, 10, pp. 2865-72

Contains fulltext : 96001.pdf (Publisher’s version ) (Closed access) OBJECTIVE: Clinical remission is the ultimate therapeutic goal in rheumatoid arthritis (RA). Although clinical trials have proven this to be a realistic goal, the concept of targe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::441671501c1ba351dc89e9246a8ed1bd
https://research.utwente.nl/en/publications/ab7b66e7-083f-46f5-bc03-b1c73df73dd3

Stable remission of early rheumatoid arthritis during tight control and treatment per protocol is achieved in ninety percent on either methotrexate alone or in combination with other DMARDS (poster)

Autor: Vermeer, M., Kuper, I., Hoekstra, M., Haagsma, C.J., van de Laar, Mart A F J

Publikováno v: None

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::de94c8b53a4d47f8524f74dbc5670960
https://research.utwente.nl/en/publications/stable-remission-of-early-rheumatoid-arthritis-during-tight-control-and-treatment-per-protocol-is-achieved-in-ninety-percent-on-either-methotrexate-alone-or-in-combination-with-other-dmards-poster(ed047c3d-9265-4f2f-b417-3c6018ae56b8).html

Vijftig procent van de patiënten met vroege reumatoide artritis bereikt binnen 25 weken remissie in de dagelijkse klinische praktijk

Autor: Kuper, I., Hoekstra, M., ten Klooster, Peter M., Vermeer, M., Haagsma, C.J., Zijlstra, T., van de Laar, Mart A F J

Publikováno v: Nederlands tijdschrift voor reumatologie, 12, 10-10. DCHG

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::3d6c0fb521a6b57aaff3f79fe11368a0
https://research.utwente.nl/en/publications/vijftig-procent-van-de-patienten-met-vroege-reumatoide-artritis-bereikt-binnen-25-weken-remissie-in-de-dagelijkse-klinische-praktijk(f5f245a2-90cc-49e9-9239-95d3167d8095).html